Cargando...
Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease
OBJECTIVE: Inflammatory bowel disease (IBD) is a chronic, autoimmune, gastrointestinal disorder. Canada has one of the highest prevalence and incidence rates of IBD in the world. Diagnosis is challenging due to the similarity of symptoms to functional gastrointestinal disorders. Faecalcalprotectin (...
Gardado en:
| Publicado en: | BMJ Open |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6500206/ https://ncbi.nlm.nih.gov/pubmed/30987989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-027043 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|